Acquired Resistance to EGFR Tyrosine Kinase Inhibitors in EGFR-Mutant Lung Cancer: Distinct Natural History of Patients with Tumors Harboring the T790M MutationGeoffrey R. Oxnard, Vincent A. Miller, William Pao et al.|Clinical Cancer Research|2010Cited by 624
Optimization of Dosing for EGFR-Mutant Non–Small Cell Lung Cancer with Evolutionary Cancer ModelingJuliann Chmielecki, William Pao, Jasmine Foo et al.|Science Translational Medicine|2011Cited by 530
New Strategies in Overcoming Acquired Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Lung CancerGeoffrey R. Oxnard, William Pao, Vincent A. Miller et al.|Clinical Cancer Research|2011Cited by 351